ID
14566
Description
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01835288
Link
https://clinicaltrials.gov/show/NCT01835288
Keywords
Versions (1)
- 4/21/16 4/21/16 -
Uploaded on
April 21, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT01835288
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT01835288
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pregnant or breast-feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C3242212
Description
investigational drug
Data type
boolean
Alias
- UMLS CUI [1]
- C0013230
Description
anti-cancer agents
Data type
boolean
Alias
- UMLS CUI [1]
- C0003392
Description
infection
Data type
boolean
Alias
- UMLS CUI [1]
- C3714514
Description
hypersensitivity to arsenic trioxide
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0052416
Similar models
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT01835288
- StudyEvent: Eligibility
C0052416 (UMLS CUI [1,2])